Home > Newsletters > FDAnews Device Daily Bulletin > FDA Expands Scope of Guidance on Presubmission Meetings
FDAnews Device Daily Bulletin
July 18, 2012 | Vol. 9 No. 140
FDA Expands Scope of Guidance on Presubmission Meetings
Under a new draft guidance, the FDA’s Pre-IDE Program will be renamed the Pre-Submission Program and cover a broad range of applications — from IDEs, PMAs and 510(k)s to humanitarian device exemptions, de novo filings and more. The change reflects the natural expansion of the agency’s Pre-IDE Program, which over time has evolved to include early feedback on a host of non-IDE submissions, the FDA explains in a Friday Federal Register notice.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.